BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Heart Electrical Conduction Abnormality Believed Not to Be Serious May Pose Cardiovascular Risks

  June 23, 2009

   · 

  1 min read
• Drug Development

  Avineuro Announces Beginning Of Phase II Clinical Studies Of AVN-397, Potent Small Molecule For Treatment Of Anxiety And Alzheimer’s Disease

  June 23, 2009

   · 

  1 min read
• Policy

  December 2009 Action Date for Schering-Plough HealthCare Products’s OTC ZEGERID New Drug Application

  June 23, 2009

   · 

  3 min read
• Biotech Beach

  Halozyme Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

  June 23, 2009

   · 

  1 min read
• BioForest

  Zymeworks Closes $3.5 Million Round of Financing and Announces Changes to its Board of Directors

  June 23, 2009

   · 

  3 min read
• Deals

  Laboratory Corporation of America Holdings (LabCorp) Enters Definitive Agreement to Acquire Monogram Biosciences for $155 Million

  June 23, 2009

   · 

  9 min read
• Policy

  IntelGenx Corp. Announces FDA Acceptance for Filing of NDA for CPI-300 Antidepressant

  June 23, 2009

   · 

  3 min read
• Drug Development

  Enzon Pharmaceuticals, Inc. Commences Phase II Trial of PEG-SN38

  June 23, 2009

   · 

  1 min read
• Business

  Lipoxen New Evaluation Agreement Signed with Major Pharma Company

  June 23, 2009

   · 

  1 min read
• Blocking A Muscle Growth-limiting Hormone Protects Against Obesity And Atherosclerosis

  June 23, 2009

   · 

  1 min read